0009K0 — Aimed Bio Balance Sheet
0.000.00%
Last trade - 00:00- KR₩4tn
- KR₩4tn
- KR₩12bn
Annual balance sheet for Aimed Bio, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Short Term Investments | ||
| Cash and Short Term Investments | 18,081 | 35,519 |
| Net Total Accounts Receivable | ||
| Net Total Receivables | 674 | 707 |
| Prepaid Expenses | ||
| Total Other Current Assets | ||
| Total Current Assets | 18,809 | 36,227 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 2,353 | 1,469 |
| Net Intangible Assets | ||
| Long Term Investments | ||
| Other Long Term Assets | ||
| Total Assets | 22,432 | 47,141 |
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Current Portion of Long Term Debt / Capital Leases | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 15,315 | 43,578 |
| Capital Lease Obligations | ||
| Total Long Term Debt | ||
| Total Debt | ||
| Minority Interest | ||
| Total Other Liabilities | ||
| Total Liabilities | 15,738 | 43,781 |
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| ESOP Debt Guarantee | ||
| Unrealized Gain / Loss | ||
| Other Equity | ||
| Total Equity | 6,694 | 3,360 |
| Total Liabilities & Shareholders' Equity | 22,432 | 47,141 |
| Total Common Shares Outstanding |